Prostate Cancer - Results from #26280

Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer - Abstract February 7, 2012

Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate - Abstract February 7, 2012

A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radioth February 7, 2012

High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: Cancer control and toxicity outcomes - Abstract February 7, 2012

GU Cancers Symposium 2012 - Empiric antibiotics for an elevated PSA: A randomized, prospective multiinstitutional trial - Session Highlights February 7, 2012

FDA approves Bayer radium-223 chloride expanded access program February 7, 2012

Study shows an investigational urine test can predict high-risk prostate cancer in men who choose ‘watchful waiting’ February 7, 2012

Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) - Abstract February 6, 2012

When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer? - Abstract February 6, 2012

Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature - Abstract February 6, 2012

Chemoprevention of prostate cancer: An updated view - Abstract February 6, 2012

Testosterone and prostate - Abstract February 6, 2012

A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer - Abstract February 6, 2012

Use of androgen deprivation therapy in prostate cancer: Indications and prevalence - Abstract February 6, 2012

Hematological changes during androgen deprivation therapy - Abstract February 6, 2012

Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis - Abstract February 6, 2012

Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract February 6, 2012

The Epigenetic promise for prostate cancer diagnosis - Abstract February 6, 2012

MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer - Abstract February 6, 2012

Study on the autophagy of prostate cancer PC-3 cells induced by oridonin - Abstract February 6, 2012

Page 1315 of 1434